• EWTX Initiated Coverage by Oppenheimer -- Rating Set to Outperfo GuruFocus Thu, 09 Jul 2026 16:18:25 GMT
• Edgewise Therapeutics' EDG-7500 Seen Entering 'Catalyst-Dense' Regulatory Period, Oppenheimer Says marketscreener.com Thu, 09 Jul 2026 15:18:31 GMT
• Oppenheimer initiates Edgewise Therapeutics stock with outperform rating By Investing.com Investing.com Canada Thu, 09 Jul 2026 12:37:36 GMT
• oppenheimer initiates edgewise therapeutics at outperform marketscreener.com Thu, 09 Jul 2026 12:20:40 GMT
• Price to book forward of Edgewise Therapeutics, Inc. – NASDAQ:EWTX TradingView Wed, 08 Jul 2026 18:25:42 GMT
• Edgewise Therapeutics stock hits all-time high at 43.96 USD By Investing.com Investing.com South Africa Wed, 08 Jul 2026 14:10:34 GMT
• edgewise therapeutics announces sale of sevasemten for up to $2.65 billion, strengthening balance sheet and centering company focu... AOL.com Tue, 07 Jul 2026 23:43:58 GMT
• Wall Street Analysts Are Bullish on Top Healthcare Picks The Globe and Mail Tue, 07 Jul 2026 12:34:00 GMT
• CYTK Stock Jumped To Over 2-Year Highs On HCM Trial Outcome – So, Why Are Analysts Bullish On Edgewise Therapeutics? Stocktwits Tue, 07 Jul 2026 03:55:16 GMT
• Guggenheim Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Raises Target Price to $51 富途牛牛 Mon, 06 Jul 2026 17:47:40 GMT
• Guggenheim raises Edgewise Therapeutics stock price target on Servier deal Investing.com Mon, 06 Jul 2026 13:46:26 GMT
• Edgewise Therapeutics(EWTX.US) Officer Sells US$7.88 Million in Common Stock Moomoo Thu, 02 Jul 2026 22:53:12 GMT
• Edgewise Therapeutics chief scientific officer Alan Russell sells $7.88m Investing.com Thu, 02 Jul 2026 21:49:29 GMT
• Form 4 Edgewise Therapeutics Inc For: 2 July By Investing.com Investing.com Canada Thu, 02 Jul 2026 21:36:48 GMT
• Edgewise Therapeutics (EWTX) CSO exercises 200K options and sells 200K shares Stock Titan Thu, 02 Jul 2026 21:21:39 GMT
• form 4 edgewise therapeutics inc for: 1 july by investing.com Investing.com Canada Thu, 02 Jul 2026 00:07:08 GMT
• form 4 edgewise therapeutics inc for: 1 july by investing.com Investing.com UK Wed, 01 Jul 2026 23:52:00 GMT
• Director Jonathan Fox of Edgewise Therapeutics (EWTX) receives 319-share stock grant Stock Titan Wed, 01 Jul 2026 23:46:49 GMT
• Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules PR Newswire Wed, 01 Jul 2026 12:00:00 GMT
• Edgewise lures 2 new employees with 16,500 stock options Stock Titan Wed, 01 Jul 2026 07:00:00 GMT
• Servier to Acquire Edgewise Therapeutics Muscular Dystrophy Business for $2.65 Billion The Healthcare Technology Report. Mon, 29 Jun 2026 12:03:20 GMT
• Is Edgewise Therapeutics, Inc. (EWTX) A Good Stock To Buy Now? Yahoo Finance Mon, 29 Jun 2026 07:00:00 GMT
• ewtx stock hits record high – why servier is shelling out $2.65b for edgewise’s muscular dystrophy business Stocktwits Mon, 29 Jun 2026 01:05:31 GMT
• edgewise shares slip after heart-disease drug trial data disappoints investors MSN Sun, 28 Jun 2026 00:10:12 GMT
• Why Edgewise Therapeutics (EWTX) Is Up 13.3% After Phase 2 EDG-7500 HCM Data Release simplywall.st Fri, 26 Jun 2026 07:00:00 GMT
• Edgewise Therapeutics, Inc. Actuals & Estimates (NASDAQ:EWTX) TradingView Fri, 26 Jun 2026 05:38:26 GMT
• Edgewise Therapeutics, Inc. (EWTX) Price Target Raised to $59 on Positive HCM Trial Data Yahoo Finance Thu, 25 Jun 2026 07:00:00 GMT
• why edgewise therapeutics (ewtx) is up 13.3% after phase 2 edg-7500 hcm data release Sahm Thu, 25 Jun 2026 07:00:00 GMT
• edgewise reports positive top-line results from phase ii cirrus-hcm trial MSN Thu, 25 Jun 2026 00:00:56 GMT
• cytk stock jumped to over 2-year highs on hcm trial outcome – so, why are analysts bullish on edgewise therapeutics? Stocktwits Wed, 24 Jun 2026 20:17:56 GMT
• 5 best healthcare stocks to buy according to wall street analysts Insider Monkey Wed, 24 Jun 2026 18:23:53 GMT
• Edgewise Therapeutics stock hits all-time high at 40.87 USD Investing.com Wed, 24 Jun 2026 07:00:00 GMT
• rbc raises price target on edgewise therapeutics to $59 from $48, keeps outperform, speculative risk Moomoo Mon, 22 Jun 2026 20:37:57 GMT
• edgewise therapeutics (ewtx) stock looks fully priced after phase 2 hcm progress simplywall.st Mon, 22 Jun 2026 07:00:00 GMT
• here's why we're not too worried about edgewise therapeutics' (nasdaq:ewtx) cash burn situation Moomoo Sat, 20 Jun 2026 14:16:01 GMT
• edgewise reports positive top-line results from phase ii cirrus-hcm trial MSN Sat, 20 Jun 2026 02:11:55 GMT
• edgewise therapeutics inc (ewtx) institutional confidence TradingKey Thu, 18 Jun 2026 23:57:52 GMT
• edgewise therapeutics inc (ewtx) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 23:38:57 GMT
• A Quick Look at Today's Ratings for Edgewise Therapeutics(EWTX.US), With a Forecast Between $41 to $59 Moomoo Thu, 18 Jun 2026 07:00:00 GMT
• how positive cirrus-hcm phase 2 data and preserved systolic function will impact edgewise therapeutics (ewtx) investors simplywall.st Wed, 17 Jun 2026 21:39:58 GMT
• edgewise therapeutics inc (ewtx) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 15:41:19 GMT
• ewtx maintained by goldman sachs -- price target raised to $32.0 GuruFocus Wed, 17 Jun 2026 15:29:54 GMT
• edgewise therapeutics inc (ewtx) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 12:09:26 GMT
• Goldman Sachs raises Edgewise Therapeutics stock price target on phase 2 data Investing.com Nigeria Wed, 17 Jun 2026 10:45:12 GMT
• Edgewise slides as cardiomyopathy challenger to BMS, Cytokinetics falls short BioSpace Wed, 17 Jun 2026 07:00:00 GMT
• RBC Capital raises Edgewise Therapeutics price target on trial data Investing.com Wed, 17 Jun 2026 07:00:00 GMT
• Edgewise Therapeutics (EWTX) director receives grant of 16,377 stock options Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• Edgewise Therapeutics (EWTX) director granted 16,377 stock options at $35.59 Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• Edgewise reports positive top-line results from Phase II CIRRUS-HCM trial Clinical Trials Arena Wed, 17 Jun 2026 07:00:00 GMT
• Edgewise Therapeutics Remains Compelling Cardiology Story Despite Atrial Fibrillation Concerns, RBC Says Moomoo Wed, 17 Jun 2026 07:00:00 GMT
• Edgewise shares slip despite positive Phase II HCM data for EDG-7500 The Pharma Letter Wed, 17 Jun 2026 07:00:00 GMT
• RBC Raises Price Target on Edgewise Therapeutics to $59 From $48, Keeps Outperform, Speculative Risk marketscreener.com Wed, 17 Jun 2026 07:00:00 GMT
• director at edgewise (nasdaq: ewtx) awarded 16,377 stock options Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• edgewise therapeutics, inc. (ewtx) discusses top line data from edg-7500 phase ii cirrus-hcm trial in hypertrophic cardiomyopathy ... Seeking Alpha Wed, 17 Jun 2026 07:00:00 GMT
• truist reiterates edgewise therapeutics stock rating on phase 2 data Investing.com UK Wed, 17 Jun 2026 01:52:50 GMT
• edgewise therapeutics (ewtx) director receives grant of 16,377 stock options Stock Titan Tue, 16 Jun 2026 22:15:48 GMT
• ewtx reiterated by hc wainwright & co. -- price target maintained at $45 GuruFocus Tue, 16 Jun 2026 19:33:00 GMT
• edgewise therapeutics (ewtx) sees significant drop in share pric GuruFocus Tue, 16 Jun 2026 19:07:30 GMT
• ewtx: edg-7500 showed strong efficacy and safety in hcm, enabling echo-independent dosing TradingView Tue, 16 Jun 2026 18:12:55 GMT
• edgewise therapeutics (ewtx) shares plunge 25% after trial update GuruFocus Tue, 16 Jun 2026 17:45:06 GMT
• buy rating reiterated on edgewise therapeutics as strong edg-7500 data and asset sale support cardiovascular pipeline; $45 price t... TipRanks Tue, 16 Jun 2026 16:07:09 GMT
• edgewise shares slip after heart-disease drug trial data disappoints investors marketscreener.com Tue, 16 Jun 2026 15:10:39 GMT
• edgewise challenges heart disease giants with safer drug profile BriefGlance Tue, 16 Jun 2026 10:00:00 GMT
• Edgewise data power rival to BMS and Cytokinetics toward phase 3 Fierce Biotech Tue, 16 Jun 2026 07:00:00 GMT
• Edgewise Therapeutics Announces Positive Top-Line Data from 12-Week Phase 2 CIRRUS-HCM Trial with EDG-7500 in Obstructive and Nono... PR Newswire Tue, 16 Jun 2026 07:00:00 GMT
• Edgewise Therapeutics Reports Improvements In Heart Drug Trial Yahoo Finance Tue, 16 Jun 2026 07:00:00 GMT
• Biotech Whips Violently Between Red And Green — What's Going On? Investor's Business Daily Tue, 16 Jun 2026 07:00:00 GMT
• [Form 4] Edgewise Therapeutics, Inc. Insider Trading Activity Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• Edgewise Therapeutics (NASDAQ: EWTX) grants director equity awards Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• Leerink reiterates Edgewise Therapeutics stock rating on trial data Investing.com Tue, 16 Jun 2026 07:00:00 GMT
• Experimental HCM drug improves symptoms without harming heartbeat Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• Edgewise heads to phase III with solid EDG-7500 data in HCM BioWorld News Tue, 16 Jun 2026 07:00:00 GMT
• truist reiterates edgewise therapeutics stock rating on phase 2 data Investing.com Tue, 16 Jun 2026 07:00:00 GMT
• edgewise stock yo-yos after phase ii data release for hcm candidate FirstWord Pharma Tue, 16 Jun 2026 07:00:00 GMT
• edgewise therapeutics advances edg-7500 to phase 3 following 'positive' hcm data marketscreener.com Tue, 16 Jun 2026 07:00:00 GMT
• edgewise posts trial data for heart disease drug (ewtx:nasdaq) Seeking Alpha Tue, 16 Jun 2026 07:00:00 GMT
• spacex, rackspace surge premarket; edgewise therapeutics, huntsman fall by investing.com Investing.com South Africa Tue, 16 Jun 2026 07:00:00 GMT
• edgewise therapeutics stock tumbles 25% on trial data by investing.com Investing.com Nigeria Tue, 16 Jun 2026 07:00:00 GMT
• edgewise to advance heart drug into phase 3 following mid-stage data update Endpoints News Tue, 16 Jun 2026 07:00:00 GMT
• edgewise reports phase 2 trial results for heart disease drug Investing.com Tue, 16 Jun 2026 07:00:00 GMT
• edgewise therapeutics price target maintained with a $45.00/share by hc wainwright & co. Moomoo Tue, 16 Jun 2026 07:00:00 GMT
• (ewtx) movement as an input in quant signal sets Stock Traders Daily Mon, 15 Jun 2026 03:48:02 GMT
• edgewise therapeutics sells muscular dystrophy business and sevasemten to servier for up to $2.65 billion Global Legal Chronicle Fri, 12 Jun 2026 00:00:00 GMT
• ewtx stock hits record high – why servier is shelling out $2.65b for edgewise’s muscular dystrophy business MSN Thu, 11 Jun 2026 09:50:10 GMT
• servier to acquire edgewise’s muscular dystrophy business for $2.65bn MSN Thu, 11 Jun 2026 08:10:22 GMT
• ewtx stock hits record high – why servier is shelling out $2.65b for edgewise’s muscular dystrophy business MSN Wed, 10 Jun 2026 00:46:30 GMT
• servier to acquire edgewise’s muscular dystrophy business for $2.65bn MSN Tue, 09 Jun 2026 14:16:19 GMT
• number of shareholders of edgewise therapeutics, inc. – nasdaq:ewtx TradingView Tue, 09 Jun 2026 08:15:23 GMT
• M c Dermott Will & Schulte advises Servier on the agreement to acquire the muscular dystrophy business of Edgewise Therapeutics McDermott Will & Schulte Tue, 09 Jun 2026 07:00:00 GMT
• vbc shortcomings, edgewise ditches dystrophy, and ffrct guidelines june 8, 2026 Cardiac Wire Mon, 08 Jun 2026 03:32:50 GMT
• do new analyst upgrades and option grants clarify edgewise therapeutics' (ewtx) long-term story? Sahm Sun, 07 Jun 2026 07:00:00 GMT
• j.p. morgan maintains edgewise therapeutics(ewtx.us) with buy rating, raises target price to $53 富途牛牛 Sat, 06 Jun 2026 19:04:29 GMT
• edgewise therapeutics, inc. 2026 annual meeting results and sec filing details Minichart Sat, 06 Jun 2026 13:52:00 GMT
• edgewise therapeutics (ewtx) shareholders approve directors, kpmg and executive pay Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• ewtx stock hits record high – why servier is shelling out $2.65b for edgewise’s muscular dystrophy business MSN Fri, 05 Jun 2026 04:37:51 GMT
• edgewise: 'buy' on muscular dystrophy program sale and edg-7500 advancement Seeking Alpha Fri, 05 Jun 2026 03:37:34 GMT
• ewtx stock hits record high – why servier is shelling out $2.65b for edgewise’s muscular dystrophy business MSN Thu, 04 Jun 2026 19:11:32 GMT
• servier to acquire edgewise’s muscular dystrophy business for $2.65bn MSN Thu, 04 Jun 2026 11:42:27 GMT
• paradigm biocapital advisors lp's edgewise therapeutics inc(ewtx) holding history GuruFocus Thu, 04 Jun 2026 08:46:59 GMT
• how edgewise sweetened its coffers by $1.55 billion, and removed a key overhang MSN Thu, 04 Jun 2026 08:33:36 GMT
• edgewise to sell muscle dystrophy business to servier for up to $2.65 billion MSN Thu, 04 Jun 2026 08:19:46 GMT
• Edgewise: 'Buy' On Muscular Dystrophy Program Sale And EDG-7500 Advancement Seeking Alpha Thu, 04 Jun 2026 07:00:00 GMT
• truist financial maintains edgewise therapeutics(ewtx.us) with buy rating, announces target price $52 富途牛牛 Thu, 04 Jun 2026 07:00:00 GMT
• h.c. wainwright maintains edgewise therapeutics(ewtx.us) with buy rating, raises target price to $45 富途牛牛 Wed, 03 Jun 2026 20:18:25 GMT
• servier to acquire edgewise muscular dystrophy business in $2.65 billion deal Indian Pharma Post Wed, 03 Jun 2026 16:18:45 GMT
• guggenheim reaffirms their buy rating on edgewise therapeutics (ewtx) The Globe and Mail Wed, 03 Jun 2026 11:52:00 GMT
• servier to acquire edgewise's muscular dystrophy drug in usd 2.65 billion deal Medical Dialogues Wed, 03 Jun 2026 10:46:47 GMT
• New Edgewise hires get 74,000 stock options as hiring inducement Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• Edgewise Therapeutics Reports Inducement Grants As Permitted By Nasdaq Listing Rules TradingView Wed, 03 Jun 2026 07:00:00 GMT
• ewtx stock hits record high – why servier is shelling out $2.65b for edgewise’s muscular dystrophy business MSN Tue, 02 Jun 2026 23:26:54 GMT
• ewtx maintained by hc wainwright & co. -- price target raised to $45 GuruFocus Tue, 02 Jun 2026 15:56:15 GMT
• ewtx maintained by wedbush -- price target raised to $52.00 GuruFocus Tue, 02 Jun 2026 15:55:26 GMT
• servier to acquire edgewise muscular dystrophy business in $2.65 billion deal Indian Pharma Post Tue, 02 Jun 2026 13:00:00 GMT
• wedbush raises edgewise therapeutics stock price target on servier deal Investing.com UK Tue, 02 Jun 2026 10:29:07 GMT
• Edgewise Therapeutics Stock Hits Record High on $2.65B Servier Deal Yahoo Finance Tue, 02 Jun 2026 07:00:00 GMT
• Assessing Edgewise Therapeutics (EWTX) Valuation After A Sharp Recent Share Price Move Yahoo Finance Tue, 02 Jun 2026 07:00:00 GMT
• David K. Lee: Servier Announces Acquisition of Edgewise Therapeutics’ Neuromuscular Business Oncodaily Tue, 02 Jun 2026 07:00:00 GMT
• Servier to buy Edgewise’s muscular dystrophy biz in $2.65bn deal BioXconomy Tue, 02 Jun 2026 07:00:00 GMT
• Servier to buy Edgewise's muscular dystrophy business for $2.65bn Pharmaceutical Technology Tue, 02 Jun 2026 07:00:00 GMT
• servier to acquire edgewise’s muscular dystrophy business for $2.65bn Pharmaceutical Technology Tue, 02 Jun 2026 07:00:00 GMT
• rbc lowers price target on edgewise therapeutics to $48 from $50, keeps outperform, speculative risk marketscreener.com Tue, 02 Jun 2026 07:00:00 GMT
• rbc capital lowers edgewise therapeutics stock price target on deal Investing.com Tue, 02 Jun 2026 07:00:00 GMT
• firm advises edgewise therapeutics on its sale of sevasemten for up to $2.65 billion Wilson Sonsini Tue, 02 Jun 2026 04:53:53 GMT
• edgewise to sell muscle dystrophy business to servier for up to $2.65 billion ETPharma.com Tue, 02 Jun 2026 02:19:51 GMT
• pharmaceutical companies focus on rare diseases: servier to acquire edgewise therapeutics’ muscular dystrophy business geneonline.com Tue, 02 Jun 2026 01:06:12 GMT
• servier moves into muscular dystrophy, paying $1.5b for assets from edgewise therapeutics RamaOnHealthcare Tue, 02 Jun 2026 00:41:41 GMT
• servier bets up to $2.7b for edgewise's late-stage muscular dystrophy asset FirstWord Pharma Mon, 01 Jun 2026 22:16:30 GMT
• this biotech snatched up $1.55 billion and removed a key overhang Investor's Business Daily Mon, 01 Jun 2026 20:31:00 GMT
• servier to acquire edgewise therapeutics (ewtx) for $2.65 billio GuruFocus Mon, 01 Jun 2026 20:15:00 GMT
• edgewise sells muscular dystrophy franchise for up to $2.65 billion, pivoting to cardiovascular growth citybiz Mon, 01 Jun 2026 15:30:21 GMT
• edgewise therapeutics sells sevasemten, refocuses on cardiology TipRanks Mon, 01 Jun 2026 13:53:17 GMT
• edgewise therapeutics sells sevasemten for up to $2.65 billion, refocuses on cardiovascular pipeline Minichart Mon, 01 Jun 2026 13:42:00 GMT
Edgewise Therapeutics, Inc(NASDAQ:EWTX) 
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. It offers a precision medicine muscle platform that generates programs to address various muscle disorders, such as Duchenne, Becker, and limb girdle muscular dystrophies. The co...
Share this website to your friends